Blau Farmacêutica S.A
Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceutical… Read more
Blau Farmacêutica S.A (BLAU3) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.059x
Based on the latest financial reports, Blau Farmacêutica S.A (BLAU3) has a cash flow conversion efficiency ratio of 0.059x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$138.88 Million) by net assets (R$2.33 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Blau Farmacêutica S.A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Blau Farmacêutica S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Blau Farmacêutica S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Blau Farmacêutica S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rorze Systems Corporation
KQ:071280
|
-0.028x |
|
Soken Chemical & Engineering Co. Ltd
MU:SOQ
|
N/A |
|
Melhus Sparebank
OL:MELG
|
0.110x |
|
MedPeerInc
PINK:MDPEF
|
N/A |
|
Zeotech Ltd
AU:ZEO
|
-0.230x |
|
Burcelik Bursa Celik Dokum Sanayi AS
IS:BURCE
|
-0.387x |
|
HMS Bergbau AG
XETRA:HMU
|
-0.399x |
|
Infant Bacterial Therapeutics AB (publ)
ST:IBT-B
|
-0.420x |
Annual Cash Flow Conversion Efficiency for Blau Farmacêutica S.A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Blau Farmacêutica S.A from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | R$2.15 Billion | R$507.20 Million | 0.236x | +150.21% |
| 2023-12-31 | R$2.00 Billion | R$188.06 Million | 0.094x | -0.32% |
| 2022-12-31 | R$1.82 Billion | R$171.90 Million | 0.095x | +0.40% |
| 2021-12-31 | R$1.63 Billion | R$153.98 Million | 0.094x | -90.80% |
| 2020-12-31 | R$221.34 Million | R$226.51 Million | 1.023x | +22.90% |
| 2019-12-31 | R$265.76 Million | R$221.29 Million | 0.833x | +125.33% |
| 2018-12-31 | R$223.33 Million | R$82.53 Million | 0.370x | -59.63% |
| 2017-12-31 | R$138.34 Million | R$126.63 Million | 0.915x | +95.36% |
| 2016-12-31 | R$97.49 Million | R$45.68 Million | 0.469x | +129.86% |
| 2015-12-31 | R$83.70 Million | R$17.06 Million | 0.204x | +15.51% |
| 2014-12-31 | R$80.58 Million | R$14.22 Million | 0.176x | +532.53% |
| 2013-12-31 | R$67.16 Million | R$-2.74 Million | -0.041x | -- |